Sunshine Biopharma (SBFM) Intangibles (2015 - 2026)
Sunshine Biopharma's Intangibles was $1.84 million in Q2 2026, down 26.0% from $2.49 million a year earlier and down 4.0% from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Intangibles (2015 - 2026) Analysis & Trends
At the end of FY2025, Intangibles at Sunshine Biopharma came in at $1.89 million, down 37.4% from FY2024.
- Intangibles shows a three-year compound annual growth rate of 34.5% (FY2022 to FY2025).
- In earlier years, Intangibles was $3.02 million in FY2024 (+109.1%), $1.44 million in FY2023 (+85.9%) and $776,856 in FY2022.
- The Q2 2026 figure marks the lowest quarterly Intangibles since Q4 2023.
- Compared with a year earlier, Intangibles has declined for four straight quarters, with growth averaging 21.5% over the last eight quarters.
- The best year-over-year quarter for Intangibles over five years was Q3 2024 (growth of 142.0%); the worst was Q1 2026 (a decline of 39.9%).
- Per Business Quant data, SBFM's Intangibles in the three quarters before Q2 2026 was $1.92 million (Q1 2026), $1.89 million (Q4 2025) and $2.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Sunshine Biopharma | 1.08 Mn | -38.01 Mn | 2.43 Mn | 1.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.84 Mn |
| Mar 31, 2026 | 1.92 Mn |
| Dec 31, 2025 | 1.89 Mn |
| Sep 30, 2025 | 2.01 Mn |
| Jun 30, 2025 | 2.49 Mn |
| Mar 31, 2025 | 3.19 Mn |
| Dec 31, 2024 | 3.02 Mn |
| Sep 30, 2024 | 2.94 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Mar 31, 2024 | 2.07 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 1.23 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 776,856.00 |
| Dec 31, 2015 | 615,038.00 |
API Access
Sunshine Biopharma Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();